US Stock MarketDetailed Quotes
XTLB XTL Biopharmaceuticals
- 2.660
- -0.140-5.00%
Close May 22 16:00 ET
- 2.820
- +0.160+6.01%
Pre 04:01 ET
14.50MMarket Cap-85809P/E (TTM)
2.695High2.650Low3.18KVolume2.653Open2.800Pre Close8.49KTurnover0.08%Turnover RatioLossP/E (Static)5.45MShares4.99052wk High5.36P/B10.99MFloat Cap0.75052wk Low--Dividend TTM4.13MShs Float600.000Historical High--Div YieldTTM1.61%Amplitude0.625Historical Low2.668Avg Price1Lot Size
XTL Biopharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -30.28%175K | -13.07%765K | -11.11%200K | -25.98%151K | -19.31%163K | 0.80%251K | -14.65%880K | -21.33%225K | -2.86%204K | -33.33%202K |
| Selling and administrative expenses | -28.99%169K | -13.65%734K | -11.42%194K | -27.86%145K | -16.04%157K | -2.06%238K | -15.08%850K | -21.79%219K | -1.47%201K | -37.04%187K |
| -General and administrative expense | -28.99%169K | -13.65%734K | -11.42%194K | -27.86%145K | -16.04%157K | -2.06%238K | -15.08%850K | -21.79%219K | -1.47%201K | -37.04%187K |
| Research and development costs | -53.85%6K | 3.33%31K | 0.00%6K | 100.00%6K | -60.00%6K | 116.67%13K | 0.00%30K | 0.00%6K | -50.00%3K | 150.00%15K |
| Operating profit | 30.28%-175K | 13.07%-765K | 11.11%-200K | 25.98%-151K | 19.31%-163K | -0.80%-251K | 14.65%-880K | 21.33%-225K | 2.86%-204K | 33.33%-202K |
| Net non-operating interest income expense | 53.85%-6K | 48.00%37K | 240.74%92K | -290.00%-19K | -283.33%-23K | -116.67%-13K | 292.31%25K | 775.00%27K | 10K | -100.00%-6K |
| Non-operating interest income | -16.67%10K | 13.89%41K | -31.25%11K | -25.00%9K | 80.00%9K | 300.00%12K | 350.00%36K | --16K | --12K | 66.67%5K |
| Non-operating interest expense | -36.00%16K | ---- | ---- | 1,300.00%28K | 190.91%32K | 177.78%25K | ---- | ---- | --2K | 83.33%11K |
| Total other finance cost | ---- | -63.64%4K | ---- | ---- | ---- | ---- | -47.62%11K | ---- | ---- | ---- |
| Other net income (expense) | 201.68%666K | -113.79%-1.05M | 68.00%-176K | 92.82%-45K | -131.17%-178K | -186.07%-655K | -133.33%-493K | -123.06%-550K | -7.18%-627K | 90.88%-77K |
| Gain on sale of security | 201.68%666K | -113.79%-1.05M | 68.00%-176K | 92.82%-45K | -131.17%-178K | -186.07%-655K | -133.33%-493K | -123.06%-550K | -7.18%-627K | 90.88%-77K |
| Income before tax | 152.77%485K | -32.20%-1.78M | 62.03%-284K | 73.81%-215K | -27.72%-364K | -281.62%-919K | -409.89%-1.35M | -135.70%-748K | -3.27%-821K | 75.22%-285K |
| Income tax | ||||||||||
| Net income | 152.77%485K | -32.20%-1.78M | 62.03%-284K | 73.81%-215K | -27.72%-364K | -281.62%-919K | -409.89%-1.35M | -135.70%-748K | -3.27%-821K | 75.22%-285K |
| Net income continuous Operations | 152.77%485K | -32.20%-1.78M | 62.03%-284K | 73.81%-215K | -27.72%-364K | -281.62%-919K | -409.89%-1.35M | -135.70%-748K | -3.27%-821K | 75.22%-285K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 152.77%485K | -32.20%-1.78M | 62.03%-284K | 73.81%-215K | -27.72%-364K | -281.62%-919K | -409.89%-1.35M | -135.70%-748K | -3.27%-821K | 75.22%-285K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 152.77%485K | -32.20%-1.78M | 62.03%-284K | 73.81%-215K | -27.72%-364K | -281.62%-919K | -409.89%-1.35M | -135.70%-748K | -3.27%-821K | 75.22%-285K |
| Basic earnings per share | 159.29%0.1 | -50.00%-0.3 | 0 | 54.08%-0.0645 | 33.20%-0.0668 | -268.65%-0.1687 | -300.00%-0.2 | -125.00%-0.1 | -40.56%-0.1406 | 50.00%-0.1 |
| Diluted earnings per share | 159.29%0.1 | -50.00%-0.3 | 0 | 54.08%-0.0645 | 33.20%-0.0668 | -281.62%-0.1687 | -447.15%-0.2 | -137.96%-0.1 | -40.56%-0.1406 | 50.00%-0.1 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg